U.S. Intravenous Immunoglobulin Market Size & Outlook

The intravenous immunoglobulin market in the United States is expected to reach a projected revenue of US$ 8,463.9 million by 2030. A compound annual growth rate of 6.7% is expected of the United States intravenous immunoglobulin market from 2024 to 2030.
Revenue, 2023 (US$M)
$5,382.9
Forecast, 2030 (US$M)
$8,463.9
CAGR, 2024 - 2030
6.7%
Report Coverage
U.S.

U.S. intravenous immunoglobulin market, 2018-2030 (US$M)

U.S.

U.S. intravenous immunoglobulin market highlights

  • The U.S. intravenous immunoglobulin market generated a revenue of USD 5,382.9 million in 2023 and is expected to reach USD 8,463.9 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
  • In terms of segment, immunodeficiency diseases was the largest revenue generating application in 2023.
  • Kawasaki Disease is the most lucrative application segment registering the fastest growth during the forecast period.

Intravenous immunoglobulin market data book summary

Market revenue in 2023USD 5,382.9 million
Market revenue in 2030USD 8,463.9 million
Growth rate6.7% (CAGR from 2023 to 2030)
Largest segmentImmunodeficiency diseases
Fastest growing segmentKawasaki Disease
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunodeficiency diseases, CIDP, Hypogammaglobulinemia, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome
Key market players worldwideBiotest AG ADR, Baxter International Inc, Grifols SA Ordinary Shares - Class A, CSL Ltd, Octapharma AG, LFB (Laboratoire Français du Fractionnement et des Biotechnologies), Taibang Biological Group, Kedrion Biopharma

Other key industry trends

  • In terms of revenue, U.S. accounted for 41.8% of the global intravenous immunoglobulin market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. intravenous immunoglobulin market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 991.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intravenous Immunoglobulin Market Scope

Intravenous immunoglobulin market segmentation & scope
Immunodeficiency diseases
CIDP
Hypogammaglobulinemia
Congenital AIDS
Chronic Lymphocytic Leukemia
Myasthenia Gravis
Multifocal Motor Neuropathy
ITP
Kawasaki Disease
Guillain-Barre Syndrome
Others
Hospital Pharmacy
Specialty Pharmacy
Others

Intravenous Immunoglobulin Market Companies

Name Profile # Employees HQ Website

U.S. intravenous immunoglobulin market size, by application, 2018-2030 (US$M)

U.S. Intravenous Immunoglobulin Market Outlook Share, 2023 & 2030 (US$M)

U.S. intravenous immunoglobulin market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more